The DOI matches its Crossref record.
Mesenchymal stem cell growth on and mechanical properties of fibrin-based biomimetic bone scaffolds
Abstract
Using the microenvironment of healing bone tissue as inspiration, this study utilized fibrin hydrogels combined with collagen type I and calcium phosphate ceramics to create a biomimetic bone scaffold. The contribution each component had on the growth of mesenchymal stem cells (hMSC) was assessed, and changes in the scaffold's mechanical properties were measured by indentation testing. The results show cell growth was greatest in scaffolds with lower concentrations of fibrinogen complex and followed a similar trend with the addition of collagen. However, cell growth was greatest in fibrin scaffolds with high concentrations of fibrinogen complex when combined with hydroxyapatite-β-tricalcium phosphate. The fibrin scaffold's stiffness does not significantly change over time, but the addition of collagen to scaffolds with low concentrations of fibrinogen complex had significant increases in stiffness by day 14. These results demonstrate that hMSC do not rapidly degrade fibrin and fibrin-collagen scaffolds in vitro. The data reported here can aid in the design and fabrication of fibrin-based engineered tissues and cell delivery vehicles that promote hMSC growth and viability as well as meet the mechanical requirements of native tissues. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 2945-2953, 2016.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BMSCs have multiple differentiation potential for therapeutic application when implanted with biodegradable scaffolds.
“Their multiple differentiation potential for therapeutic application when implanted with biodegradable scaffolds has been demonstrated in several previous studies [16–19].”
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 44
- Marino, 2010, Use of solid and cancellous autologous bone graft for fractures and nonunions, Orthop Clin North Am, 41, 15, 10.1016/j.ocl.2009.08.003 · DOI
- Desai, 2007, Osteobiologics, Am J Orthop (Belle Mead, N.J.), 36, 8
- Langer, 1993, Tissue engineering, Science, 260, 920, 10.1126/science.8493529 · DOI · Paper page
- Service, 2000, Tissue engineers build new bone, Science, 289, 1498, 10.1126/science.289.5484.1498 · DOI
- Greenwald, 2001, Comm Biological I. Bone-graft substitutes: Facts, fictions, and applications, J Bone Joint Surg Am, 83A, 98, 10.2106/00004623-200100022-00007 · DOI
- Amini, 2012, Bone tissue engineering: Recent advances and challenges, Crit Rev Biomed Eng, 40, 363, 10.1615/CritRevBiomedEng.v40.i5.10 · DOI
- Nuss, 2008, Biocompatibility issues with modern implants in bone-A review for clinical orthopedics, Open Orthop J, 2, 66, 10.2174/1874325000802010066 · DOI
- Zara, 2011, High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo, Tissue Eng Part A, 17, 1389, 10.1089/ten.tea.2010.0555 · DOI · Paper page
- Cowan, 2007, MicroCT evaluation of three-dimensional mineralization in response to BMP-2 doses in vitro and in critical sized rat calvarial defects, Tissue Eng, 13, 501, 10.1089/ten.2006.0141 · DOI
- Robey, 2011, Cell sources for bone regeneration: The good, the bad, and the ugly (but promising), Tissue Eng Part B, 17, 423, 10.1089/ten.teb.2011.0199 · DOI
- Papadimitropoulos, 2015, Engineered decellularized matrices to instruct bone regeneration processes, Bone, 70, 66, 10.1016/j.bone.2014.09.007 · DOI
- Willerth, 2006, Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells, Biomaterials, 27, 5990, 10.1016/j.biomaterials.2006.07.036 · DOI
- Ho, 2006, The behavior of human mesenchymal stem cells in 3D fibrin clots: Dependence on fibrinogen concentration and clot structure, Tissue Eng, 12, 1587, 10.1089/ten.2006.12.1587 · DOI
- Catelas, 2006, Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro, Tissue Eng, 12, 2385, 10.1089/ten.2006.12.2385 · DOI
- Linsley, 2013, The effect of fibrinogen, collagen type I, and fibronectin on mesenchymal stem cell growth and differentiation into osteoblasts, Tissue Eng Part A, 19, 1416, 10.1089/ten.tea.2012.0523 · DOI
- Duong, 2009, Modulation of 3D fibrin matrix stiffness by intrinsic fibrinogen-thrombin compositions and by extrinsic cellular activity, Tissue Eng Part A, 15, 1865, 10.1089/ten.tea.2008.0319 · DOI
- Reinertsen, 2014, Concentration of fibrin and presence of plasminogen affect proliferation, fibrinolytic activity, and morphology of human fibroblasts and keratinocytes in 3D fibrin constructs, Tissue Eng Part A, 20, 2860, 10.1089/ten.tea.2013.0423 · DOI
- Cole, 2007, Fibrin as a delivery vehicle for active macrophage activator lipoprotein-2 peptide: In vitro studies, Wound Repair Regen, 15, 521, 10.1111/j.1524-475X.2007.00260.x · DOI
- Spotnitz, 2014, Fibrin sealant: The only approved hemostat, sealant, and adhesive-a laboratory and clinical perspective, ISRN Surg, 2014, 203943, 10.1155/2014/203943 · DOI
- Fortunato, 1997, Long-term results of hydroxyapatite-fibrin glue implantation in plastic and reconstructive craniofacial surgery, J Craniomaxillofac Surg, 25, 124, 10.1016/S1010-5182(97)80003-0 · DOI
- Hong, 2006, The effect of a fibrin-fibronectin/beta-tricalcium phosphate/recombinant human bone morphogenetic protein-2 system on bone formation in rat calvarial defects, Biomaterials, 27, 3810, 10.1016/j.biomaterials.2006.02.045 · DOI
- Cummings, 2004, Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures, Biomaterials, 25, 3699, 10.1016/j.biomaterials.2003.10.073 · DOI
- Nudelman, 2010, The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors, Nat Mater, 9, 1004, 10.1038/nmat2875 · DOI
- Bensaid, 2003, A biodegradable fibrin scaffold for mesenchymal stem cell transplantation, Biomaterials, 24, 2497, 10.1016/S0142-9612(02)00618-X · DOI
- Cordonnier, 2009, 3D environment on human mesenchymal stem cells differentiation for bone tissue engineering, J Mater Sci, 21, 981
- Buchta, 2005, Biochemical characterization of autologous fibrin sealants produced by CryoSeal (R) and Vivostat (R) in comparison to the homologous fibrin sealant product Tissucol/Tisseel (R), Biomaterials, 26, 6233, 10.1016/j.biomaterials.2005.04.014 · DOI
- Mooney, 2005, Indentation micromechanics of fibroblast-populated fibrin constructs. Structure and mechanical behavior of biological materials, MRS Proc, 874, 205, 10.1557/PROC-874-L7.10 · DOI
- Mooney, 2006, Indentation micromechanics of three-dimensional fibrin/collagen biomaterial scaffolds, J Mater Res, 21, 2023, 10.1557/jmr.2006.0258 · DOI
- Wells, 2008, The role of matrix stiffness in regulating cell behavior, Hepatology, 47, 1394, 10.1002/hep.22193 · DOI
- Lund, 2008, Osteogenic differentiation of mesenchymal stem cells in defined protein beads, J Biomed Mater Res Part B, 87B, 213, 10.1002/jbm.b.31098 · DOI
- Hong, 2007, The role of ERK signaling in protein hydrogel remodeling by vascular smooth muscle cells, Biomaterials, 28, 3824, 10.1016/j.biomaterials.2007.05.007 · DOI
- Brannvall, 2007, Enhanced neuronal differentiation in a three-dimensional collagen-hyaluronan matrix, J Neurosci Res, 85, 2138, 10.1002/jnr.21358 · DOI
- Heckmann, 2006, Mesenchymal progenitor cells communicate via alpha and beta integrins with a three-dimensional collagen type I matrix, Cells Tissues Organs, 182, 143, 10.1159/000093964 · DOI
- Sun, 1997, Effect of hydroxyapatite particle size on myoblasts and fibroblasts, Biomaterials, 18, 683, 10.1016/S0142-9612(96)00183-4 · DOI
- Maeno, 2005, The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture, Biomaterials, 26, 4847, 10.1016/j.biomaterials.2005.01.006 · DOI
- Rowe, 2006, Interpenetrating collagen-fibrin composite matrices with varying protein contents and ratios, Biomacromolecules, 7, 2942, 10.1021/bm0602233 · DOI
- Ariens, 2002, Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms, Blood, 100, 743, 10.1182/blood.V100.3.743 · DOI
- Shikanov, 2009, Interpenetrating fibrin-alginate matrices for in vitro ovarian follicle development, Biomaterials, 30, 5476, 10.1016/j.biomaterials.2009.06.054 · DOI
- Ye, 2000, Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering, Eur J Cardiothorac Surg, 17, 587, 10.1016/S1010-7940(00)00373-0 · DOI
- Sacchi, 2014, Long-lasting fibrin matrices ensure stable and functional angiogenesis by highly tunable, sustained delivery of recombinant VEGF(164), Proc Natl Acad Sci USA, 111, 6952, 10.1073/pnas.1404605111 · DOI
- Perka, 2000, Joint cartilage repair with transplantation of embryonic chondrocytes embedded in collagen-fibrin matrices, Clin Exp Rheumatol, 18, 13
- Dikovsky, 2006, The effect of structural alterations of PEG-fibrinogen hydrogel scaffolds on 3-D cellular morphology and cellular migration, Biomaterials, 27, 1496, 10.1016/j.biomaterials.2005.09.038 · DOI
- Koellmer, 2012, Stem cell-derived extracellular matrix enables survival and multi lineage differentiation within superporous hydrogels, Biomacromolecules, 13, 963, 10.1021/bm300332w · DOI
- Rowe, 2007, Influence of thrombin concentration on the mechanical and morphological properties of cell-seeded fibrin hydrogels, Acta Biomater, 3, 59, 10.1016/j.actbio.2006.08.006 · DOI
Cited by
Sorted by citations
Mao, M., Qu, X., Zhang, Y., Gu, B., Li, C., Liu, R., Li, X., Zhu, H., He, J., & Li, D. (2023) · Nature Communications · doi:10.1038/s41467-023-37716-1 · Cited by 42
Bi, F., Chen, Y., Liu, J., Hu, W., & Tian, K. (2021) · Stem Cells International · doi:10.1155/2021/6697969 · Cited by 18
Metadata
- Authors
- Linsley, C. S., Wu, B. M., & Tawil, B.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Tawil, Bill
- Venue
- Journal of Biomedical Materials Research Part A
- Publisher
- Wiley
- Published
- 2016-08-01
- Volume
- 104
- Issue
- 12
- Pages
- 2945-2953
- ISSN
- 1549-3296 (ISSN-L)
- OpenAlex
- W2480281633
- Cited by
- 30
- References
- 0
- Citations by year
- 2024: 7 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 1 · 2019: 4 · 2018: 2 · 2017: 6
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Biomedical Materials Research Part A (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
- Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Keywords
- mesenchymal stem cells, fibrin gel, type I collagen, calcium phosphate ceramics, hydroxyapatite, beta-tricalcium phosphate, scaffold mechanical properties, scaffold stiffness, cell growth, tissue engineering, cell delivery vehicle, scaffold degradation
- MeSH terms
- Calcium Phosphates, Cell Line, Cell Survival, Fibrin, Humans, Durapatite, Biomimetics, Cell Proliferation, Tissue Scaffolds, Elastic Modulus, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review